Related Experiment Videos

Selectivity of omega-conotoxin GVIA for n-type calcium channels in rat isolated small mesenteric arteries

S L Whorlow1, J A Angus, C E Wright

  • 1Department of Pharmacology, University of Melbourne, Victoria, Australia.

Insights

Omega-conotoxin GVIA selectively blocks prejunctional N-type voltage-operated calcium channels (VOCC) in mesenteric arteries, inhibiting neurotransmitter release without affecting smooth muscle contraction mediated by L-type VOCC.

Area of Science:

  • Pharmacology
  • Neuroscience
  • Cardiovascular Physiology

Background:

  • Voltage-operated calcium channels (VOCC) play critical roles in neurotransmission and smooth muscle contraction.
  • N-type VOCC are implicated in neurotransmitter release at the vascular neuroeffector junction.
  • L-type VOCC mediate smooth muscle depolarization and vasoconstriction.

Purpose of the Study:

  • To investigate the selectivity of omega-conotoxin GVIA (omega-CTX) for prejunctional N-type VOCC.
  • To compare the effects of omega-CTX with felodipine, an L-type VOCC blocker, on vascular responses.
  • To determine the impact of omega-CTX on neurotransmitter release versus direct smooth muscle activation.

Main Methods:

  • Rat isolated small mesenteric arteries were mounted in a Mulvany-Halpern myograph.
  • Contractile responses to perivascular nerve stimulation, noradrenaline, and potassium were measured.
  • Vessels were treated with varying concentrations of omega-CTX or felodipine.

Main Results:

  • Omega-CTX (3 nmol/L–10 μmol/L) inhibited nerve stimulation-induced contractions by up to 94%.
  • Omega-CTX did not affect contractions to exogenous noradrenaline or potassium.
  • Felodipine significantly reduced contractions to noradrenaline and potassium, but had minimal effect on nerve stimulation-induced contractions.

Conclusions:

  • Omega-conotoxin GVIA demonstrates high selectivity for prejunctional N-type VOCC.
  • Omega-CTX inhibits neurotransmitter release without affecting post-junctional L-type VOCC-mediated responses.
  • These findings distinguish omega-CTX from L-type VOCC blockers like felodipine in vascular preparations.

Related Concept Videos